Global Patent Index - EP 1282640 A2

EP 1282640 A2 20030212 - NUCLEIC ACID IMMUNIZATION

Title (en)

NUCLEIC ACID IMMUNIZATION

Title (de)

IMPFUNG DURCH NUKLEINSÄURE

Title (fr)

IMMUNISATION AU MOYEN D'ACIDE NUCLEIQUE

Publication

EP 1282640 A2 20030212 (EN)

Application

EP 01925706 A 20010501

Priority

  • GB 0101924 W 20010501
  • US 56195100 A 20000501
  • US 20096800 P 20000501
  • US 21058000 P 20000608

Abstract (en)

[origin: WO0183528A2] An immune response against an influenza virus is elicited in a subject by administering a vaccine composition comprising a nucleic acid sequence that encodes an influenza virus M2 antigen. The nucleic acid sequence is not present in a recombinant viral vector. The nucleic acid sequence is expressed in the subject to provide the influenza virus M2 antigen in an amount sufficient to elicit an immune response.

IPC 1-7

C07K 14/005

IPC 8 full level

C07K 14/11 (2006.01)

CPC (source: EP)

C07K 14/005 (2013.01); A61K 2039/53 (2013.01); A61K 2039/55561 (2013.01); C12N 2760/16122 (2013.01)

Citation (search report)

See references of WO 0183528A2

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 0183528 A2 20011108; WO 0183528 A3 20020425; AU 5239001 A 20011112; EP 1282640 A2 20030212

DOCDB simple family (application)

GB 0101924 W 20010501; AU 5239001 A 20010501; EP 01925706 A 20010501